Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07289165 · ClinicalTrials.gov registry record · NA

Comparison of Pharmacokinetic Responses to Three Ketone Esters

A NA study of Healthy Volunteer, sponsored by NeuroEnergy Ventures.

Active
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT07289165: Active NA study of Healthy Volunteer, sponsored by NeuroEnergy Ventures.

NCT07289165 is a NA study of Healthy Volunteer that is active but no longer recruiting, run by NeuroEnergy Ventures. The registered enrollment target is 18 participants, below the 202-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07289165, a NA study of Healthy Volunteer, is active but no longer recruiting, sponsored by NeuroEnergy Ventures.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine how the body absorbs, digests, and metabolizes three different investigational ketone dietary supplements (ketone monoester, ketone tri-ester, ketone salt) and to assess gastrointestinal tolerance or other adverse effects. This study is considered investigational because data are being collected on the differences over time between three active study products. Consumption of these study products are not intended to diagnose, treat, cure, or prevent any disease.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Dietary Supplement containing Tri-betahydroxybutyrin
  • DIETARY_SUPPLEMENT Dietary Supplement containing a ketone mono Ester
  • DIETARY_SUPPLEMENT Dietary supplement containing a ketone salt

Study Locations (1)

Ohio

  • CAHS - Canfield

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2025-07-15
Est. Completion 2026-02
Phase NA
NeuroEnergy Ventures

2 total trials

What the registry record for NCT07289165 still lists

NCT07289165 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 202-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Healthy Volunteer appearing as the primary indexed condition, and to 3 interventions - of which Dietary Supplement containing Tri-betahydroxybutyrin is the first listed.

NCT07289165 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07289165 about?

NCT07289165 is a clinical study titled "Comparison of Pharmacokinetic Responses to Three Ketone Esters". The purpose of this study is to examine how the body absorbs, digests, and metabolizes three different investigational ketone dietary supplements (ketone monoester, ketone tri-ester, ketone salt) and to assess gastrointestinal tolerance or other adverse effects. This study is considered investigatio...

What is the current status of trial NCT07289165?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-07-15. Estimated completion is 2026-02.

What conditions does trial NCT07289165 study?

This clinical trial studies the following conditions: Healthy Volunteer.

What interventions are being tested in trial NCT07289165?

The interventions under investigation include: Dietary Supplement containing Tri-betahydroxybutyrin (DIETARY_SUPPLEMENT), Dietary Supplement containing a ketone mono Ester (DIETARY_SUPPLEMENT), Dietary supplement containing a ketone salt (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07289165?

This trial is sponsored by NeuroEnergy Ventures, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07289165 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07289165's enrollment target sits among peer trials

18 98th of 112 higher than 14 of 112 other Healthy Volunteer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Volunteer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07289165, the US trial registry maintained by the National Library of Medicine. NCT07289165 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.